FDA weighs fate of Qnexa for weight loss, again - KFDA
USA TODAYFDA weighs fate of Qnexa for weight loss, againKFDA21 (HealthDay News) -- The US Food and Drug Administration plans to take a second look at the weight loss pill Qnexa on Wednesday, after initially rejecting it because of concerns about heart problems and possible birth defects.FDA Says Weight Loss Drug Needs CV Outcome TrialFamily Practice News Digital NetworkFDA to review rejected weight loss drug QnexaNews-Medical.netPanel to ponder fate of weight-loss pillKTVQ Billings NewsSeeking Alpha -allvoices -1590 KLIV Silicon Valley Newsall 82 news articles »...
Published By: Weight-loss - Tuesday, 21 February
- Older News
- FDA warns against illegal HCG diet supplements - WAFF
Weight-loss Supplements (3 days ago) - FDA warns against illegal HCG diet supplementsWAFF... Commission (FTC) and the FDA issued letters to businesses selling HCG warning they are selling illegal weight loss drugs that are not FDA...
